{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:55:14Z","timestamp":1782863714751,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01063-2","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:26:22Z","timestamp":1765358782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Appropriateness of proton pump inhibitor prescription for prevention of gastrointestinal bleeding in patients receiving warfarin: a real world, database study"],"prefix":"10.1186","volume":"27","author":[{"given":"Panisa","family":"Manasirisuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittisak","family":"Sawanyawisuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witsarut","family":"Manasirisuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"1063_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013156.","journal-title":"Circulation"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/JBM.S41404","volume":"4","author":"D Snipelisky","year":"2013","unstructured":"Snipelisky D, Kusumoto F. Current strategies to minimize the bleeding risk of warfarin. J Blood Med. 2013;4:89\u201399.","journal-title":"J Blood Med"},{"issue":"12","key":"1063_CR3","doi-asserted-by":"publisher","first-page":"e24522","DOI":"10.1097\/MD.0000000000024522","volume":"100","author":"T Ma","year":"2021","unstructured":"Ma T, Liu C, Jiang T, Qin H, Wu R, Zhou P. Comparative risk for intracranial hemorrhage related to new oral anticoagulants. Med (Baltim). 2021;100(12):e24522.","journal-title":"Med (Baltim)"},{"key":"1063_CR4","doi-asserted-by":"crossref","unstructured":"Hanon O, Vidal JS, Pisica-Donose G, Orvo\u00ebn G, David JP, Chaussade E, et al. Bleeding risk with Rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation. Heart. 2021 Sept;107(17):1376\u201382.","DOI":"10.1136\/heartjnl-2020-317923"},{"key":"1063_CR5","doi-asserted-by":"crossref","unstructured":"Lin KJ, Hern\u00e1ndez-D\u00edaz S, Garc\u00eda Rodr\u00edguez LA. Acid suppressants reduce risk of Gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology. 2011 July;141(1):71\u20139.","DOI":"10.1053\/j.gastro.2011.03.049"},{"issue":"4","key":"1063_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10557-021-07170-6","volume":"36","author":"SR Lee","year":"2022","unstructured":"Lee SR, Kwon S, Choi EK, Jung JH, Han KD, Oh S, et al. Proton pump inhibitor Co-Therapy in patients with atrial fibrillation treated with oral anticoagulants and a prior history of upper Gastrointestinal tract bleeding. Cardiovasc Drugs Ther. 2022;36(4):679\u201389.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"1063_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1053\/j.gastro.2016.08.054","volume":"151","author":"WA Ray","year":"2016","unstructured":"Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, et al. Association of proton pump inhibitors with reduced risk of Warfarin-Related serious upper Gastrointestinal bleeding. Gastroenterology. 2016;151(6):1105\u2013e111210.","journal-title":"Gastroenterology"},{"issue":"5","key":"1063_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"DJ Kumbhani","year":"2021","unstructured":"Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: A report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021;77(5):629\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.11.014","volume":"85","author":"MG Abrignani","year":"2021","unstructured":"Abrignani MG, Gatta L, Gabrielli D, Milazzo G, De Francesco V, De Luca L, et al. Gastroprotection in patients on antiplatelet and\/or anticoagulant therapy: a position paper of National association of hospital cardiologists (ANMCO) and the Italian association of hospital gastroenterologists and endoscopists (AIGO). Eur J Intern Med. 2021;85:1\u201313.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1063_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154(5):1121\u2013201.","journal-title":"Chest"},{"issue":"2","key":"1063_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1358863X18815971","volume":"24","author":"JE Kurlander","year":"2019","unstructured":"Kurlander JE, Gu X, Scheiman JM, Haymart B, Kline-Rogers E, Saini SD, et al. Missed opportunities to prevent upper GI hemorrhage: the experience of the Michigan anticoagulation quality improvement initiative. Vasc Med. 2019;24(2):153\u20135.","journal-title":"Vasc Med"},{"issue":"1","key":"1063_CR12","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1038\/s41467-024-48007-8","volume":"15","author":"B Xia","year":"2024","unstructured":"Xia B, He Q, Smith FG, Gkoutos VG, Nirantharakumar K, Kuo ZC, et al. Individualized prevention of proton pump inhibitor related adverse events by risk stratification. Nat Commun. 2024;15(1):3591.","journal-title":"Nat Commun"},{"key":"1063_CR13","doi-asserted-by":"crossref","unstructured":"Ladd AM, Panagopoulos G, Cohen J, Mar N, Graham R. Potential costs of inappropriate use of proton pump inhibitors. Am J Med Sci. 2014 June;347(6):446\u201351.","DOI":"10.1097\/MAJ.0b013e31829f87d5"},{"key":"1063_CR14","doi-asserted-by":"crossref","unstructured":"Salvo EM, Ferko NC, Cash SB, Gonzalez A, Kahrilas PJ. Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors. Aliment Pharmacol Ther. 2021 July;54(2):129\u201343.","DOI":"10.1111\/apt.16407"},{"issue":"9","key":"1063_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-023-03534-z","volume":"79","author":"LGT Shanika","year":"2023","unstructured":"Shanika LGT, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79(9):1159\u201372.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1063_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.25100\/cm.v44i1.1028","volume":"44","author":"J Machado-Alba","year":"2013","unstructured":"Machado-Alba J, Fern\u00e1ndez A, Castrill\u00f3n JD, Campo CF, Echeverri LF, Gaviria A, et al. Prescribing patterns and economic costs of proton pump inhibitors in Colombia. Colomb Med (Cali). 2013;44(1):13\u20138.","journal-title":"Colomb Med (Cali)"},{"issue":"5","key":"1063_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1756283X17694807","volume":"10","author":"R Sharma","year":"2017","unstructured":"Sharma R, Roy A, Ramos C, Rosenberg R, Garcia-Carrasquillo R, Lebwohl B. Low adherence to National guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation. Th Adv Gastroenterol. 2017;10(5):387\u201396.","journal-title":"Th Adv Gastroenterol"},{"issue":"1","key":"1063_CR18","first-page":"45","volume":"63","author":"M Hata","year":"2015","unstructured":"Hata M, Shiono M, Akiyama K, Sezai A, Wakui S, Kimura H, et al. Incidence of drug interaction when using proton pump inhibitor and warfarin according to cytochrome P450 2C19 (CYP2C19) genotype in Japanese. Thorac Cardiovasc Surg. 2015;63(1):45\u201350.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"9","key":"1063_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ueg2.12448","volume":"11","author":"YS Jung","year":"2023","unstructured":"Jung YS, Park JH, Park CH. Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta-analysis. United Eur Gastroenterol J. 2023;11(9):861\u201373.","journal-title":"United Eur Gastroenterol J"},{"issue":"48","key":"1063_CR20","doi-asserted-by":"publisher","first-page":"e31953","DOI":"10.1097\/MD.0000000000031953","volume":"101","author":"C Lu","year":"2022","unstructured":"Lu C, Zhang Y. Gastrointestinal bleeding during the transcatheter aortic valve replacement perioperative period: A review. Med (Baltim). 2022;101(48):e31953.","journal-title":"Med (Baltim)"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01063-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:56:20Z","timestamp":1768384580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01063-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01063-2","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the Declaration of Helsinki. The study protocol was approved by the Khon Kaen University Ethics Committee for Human Research (Reference No. HE661254). The Khon Kaen University Ethics Committee for Human Research waived the requirement for informed consent due to the retrospective nature of the study, which involved the analysis of de-identified data from a hospital database. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}